Healthy Extracts (HYEX) Net Equity Issued and Repurchased (2015 - 2023)

Healthy Extracts has reported Net Equity Issued and Repurchased for 5 years, with the latest figure at -$55000.0 in Q4 2023.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$55000.0 in Q4 2023; TTM through Sep 2024 was -$55000.0, a 57.14% decrease from a year earlier, with the FY2023 full-year figure at -$90000.0, down 690.44% from the prior year.
• Net Equity Issued and Repurchased was -$55000.0 for Q4 2023 at Healthy Extracts, down from -$35000.0 in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $2.1 million in Q3 2020, with the low at -$1.7 million in Q4 2020.
• Average Net Equity Issued and Repurchased over 4 years is $124517.6, with a median of -$31708.5 recorded in 2022.
• The sharpest annual moves came in 2021 and 2023: Net Equity Issued and Repurchased soared 144.39% in 2021, then tumbled 164.54% in 2023.
• Over 4 years, Net Equity Issued and Repurchased stood at -$1.7 million in 2020, then soared by 144.39% to $770199.0 in 2021, then slumped by 92.96% to $54231.0 in 2022, then tumbled by 201.42% to -$55000.0 in 2023.
• The last three Net Equity Issued and Repurchased figures came in at -$55000.0 (Q4 2023), -$35000.0 (Q3 2023), and $54231.0 (Q3 2022), per Business Quant data.